A one-step assay for sorted CD3(+) cell purity and chimerism after hematopoietic stem cell transplantation

Archive ouverte

Desoutter, Judith | Usureau, Cedric | Jacob, Valentine | Lebon, Delphine | Caulier, Alexis | da Costa, Cecilia | Charbonnier, Amandine | Joris, Magalie | Marolleau, Jean-Pierre | Guillaume, Nicolas

Edité par CCSD ; Wiley -

International audience. A hematopoietic chimerism assay is the laboratory test for monitoring engraftment and quantifying the proportions of donor and recipient cells after hematopoietic stem cell transplantation recipients. Flow cytometry is the reference method for determining the purity of CD3(+) cells on the chimerism of selected CD3(+) cells. In the present study, we developed a single-step procedure that combines the CD3(+) purity assay (using the PCR-based Non-T Genomic Detection Kit from Accumol, Calgary, Canada) and the qPCR chimerism monitoring assay (the QTRACE qPCR assay from Jeta Molecular, Utrecht, the Netherlands). First, for the CD3(+) purity assay, we used a PCR-friendly protocol by changing the composition of the ready-to-use reaction tubes (buffer and taq polymerase) and obtained a satisfactory calibration plot (R-2 = 0.8924) with a DNA reference scale of 2 ng/mu l. Next, 29 samples (before and after CD3 positive selection) were analyzed, the mean cell purity was, respectively, 19.6% +/- 6.45 and 98.9% +/- 1.07 in the flow cytometry assay; 26.8% +/- 7.63 and 98.5% +/- 1.79 in the PCR-based non-T genomic detection assay. Our results showed that the CD3(+) purity assay using a qPCR kit is a robust alternative to the flow cytometry assay and is associated with time savings when combined with a qPCR chimerism assay.

Consulter en ligne

Suggestions

Du même auteur

Immunomodulation with azacytidine and donor lymphocyte infusion following sequential conditioning allogenic stem cell transplantation improves outcome of unfavorable AML

Archive ouverte | Joris, Magalie | CCSD

61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Orlando, FL, DEC 07-10, 2019. International audience. Background:Patients with acute myeloid leukemia in relapse or refractory to induc...

Ruxolitinib-induced reactivation of cytomegalovirus and Epstein-Barr virus in graft-versus-host disease

Archive ouverte | Lebon, Delphine | CCSD

International audience. Objectives: Steroid-refractory graft-versus-host disease (SR-GVHD) is a challenging complication of allogeneic hematopoietic stem cell transplantation, and leads to high morbidity and mortali...

One-step check purity of CD3+sorted cells during monitoring of hematopoietic chimaerism after HSCT

Archive ouverte | Desoutter, Judith | CCSD

Special Issue: Abstracts for the Joint 34th European Immunogenetics and Histocompatibility and 31st British Society for Histocompatibility and Immunogenetics Conference Glasgow, Scotland, United Kingdom, April 26‐29, 2020 Oral pre...

Chargement des enrichissements...